search
Back to results

Effects of Fluid Balance Control in Critically Ill Patients (POINCARE)

Primary Purpose

Fluid Shifts, Critical Care

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
diuretics
albumin
fluid restriction
renal replacement
Sponsored by
Central Hospital, Nancy, France
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fluid Shifts focused on measuring Fluid overload, Multiple organ failure, Diuretics, Fluid restriction, Body weight

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients under mechanical ventilation, admitted for > 48h and <72h and no discharge planned for the next 24h

Exclusion Criteria:

  • Age < 18 years
  • Failure to weigh the patient
  • Multiple trauma
  • Transfer from another ICU with a previous stay > 24h
  • High probability of withdrawing treatment for ethical purposes within 7 days
  • Pregnancy
  • Patient refusal

Sites / Locations

  • Hopital Nord Franche-Comté
  • Centre Hospitalier Universitaire
  • Centre Hospitalier Universitaire
  • Centre Hospitalier Régional
  • Centre Hospitalier Régional et Universitaire
  • Groupe Hospitalier Saint Joseph
  • Centre Hospitalier intercommunal
  • Centre Hospitalier Régional et Universitaire
  • CentreHospitalier Régional et universitaire
  • Centre Hospitalier Régional
  • Centre Hospitalier

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Strategy

Arm Description

Usual care provided according to the ward policy. Patients have to be weighed at least on admission (day 0), day 7 and day 14.

Patients have to be weighed every day. Use of an algorithm based on weight changes from day 2 to day 14 in order to reduce weight gain (fluid overload) using diuretics, fluid restriction,albumin, and ultrafiltration (the latter when ongoing renal replacement)

Outcomes

Primary Outcome Measures

All-cause mortality at 60 days after inclusion
Vital status collected 60 days after admission; if the patient was dead at the time of assessment, date of death was collected

Secondary Outcome Measures

Fluid balance control at day 7
Mean differences of patient body weight between Day 7 and admission (Day 0)
Fluid balance control at day 14
Mean differences of patient body weight between Day 14 and admission (Day 0)
All-cause mortality at 28-day after inclusion
Vital status collected 28 days after admission
All-cause in-hospital mortality
Death during the hospital stay where the patient was included in the study
All-cause mortality at 365 days after inclusion
Vital status collected one year after admission
Survival time period at Day 60
Time-related mortality, calculated from admission to the date of death
Survival time period at Day 365
Time-related mortality, calculated from admission to the date of death
Global end-organ damage assessment
Time-related changes of Sequential Organ Failure Assessment (SOFA score): SOFA is a score of organ failure with 6 subscales on organ dysfunction: respiratory, neurological, cardiovascular,hepatic,renal and coagulation. Each ranges from 0 to 4 and the total SOFA score is the sum of each subscale ; increasing severity from 0 (normal) to 24(moribund). Values of SOFA score are tightly correlated with mortality.
Dependence on vasopressor drugs
Cumulated number of vasopressor-free days alive from day 0 to day 28
Dependence on mechanical ventilation
Cumulated number of ventilator-free days alive from day 0 to day 28
Dependence on renal replacement therapy
Cumulated number of renal replacement-free days alive from day 0 to day 60
Cumulated number of pre-defined adverse events
Pre-defined adverse events include Systolic arterial pressure< 90 mm Hg, kalemia < 2,8 ,mmol/L, natremia >155 mmol/L, "injury" level of renal dysfunction (RIFLE scale), acute ischemic events (myocardial infarction, mesenteric ischemia)

Full Information

First Posted
April 29, 2016
Last Updated
September 21, 2020
Sponsor
Central Hospital, Nancy, France
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT02765009
Brief Title
Effects of Fluid Balance Control in Critically Ill Patients
Acronym
POINCARE
Official Title
Effects of Fluid Balance Control in Critically Ill Patients: A Multicenter Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
June 1, 2016 (Actual)
Primary Completion Date
July 31, 2019 (Actual)
Study Completion Date
May 25, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Central Hospital, Nancy, France
Collaborators
Ministry of Health, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Most ICU patients develop a positive fluid balance, mainly during the two first weeks of their stay. The causes are multifactorial: a reduced urine output subsequent to shock state, positive pressure mechanical ventilation, acute renal failure, post-operative period of major surgical procedures, and simultaneous fluid loading to maintain volemia and acceptable arterial pressure. Additionally, the efficacy of fluid loading is frequently suboptimal, in relation to severe hypoalbuminemia and inflammatory capillary leakage. This results usually in a cumulated positive fluid balance of more than 10 litres at the end of the first week of stay. A high number of studies have showed that such a positive fluid balance was an independent factor of worse prognosis in selected populations of ICU patients: acute renal failure, acute respiratory distress syndrome (ARDS), sepsis, post-operative of high risk surgery. However, little is known about the putative causal role of positive fluid balance by itself on outcome. However, in two randomized controlled studies in patients with ARDS, a strategy of fluid balance control has been demonstrated to reduce time under mechanical ventilation and ICU length of stay with no noticeable adverse effects. Although avoiding fluid overload is now recommended in ARDS management, there is no evidence that this approach would be beneficial in a more general population of ICU patients (i.e. with sepsis, acute renal failure, mechanical ventilation). In addition, fluid restriction -mainly if applied early could be deleterious in reducing both tissue oxygen delivery and perfusion pressure. There is a place for a prospective study comparing a "conventional" attitude based on liberal fluid management throughout the ICU stay with a restrictive approach aiming at controlling fluid balance, at least as soon as the patient circulatory status is stabilized. The latter approach would use a simple algorithm using fluid restriction and diuretics based on daily weighing, a common procedure in the ICU, probably more reliable than cumulative measurement of fluid movements in patients whose limits have been underlined.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fluid Shifts, Critical Care
Keywords
Fluid overload, Multiple organ failure, Diuretics, Fluid restriction, Body weight

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1411 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual care provided according to the ward policy. Patients have to be weighed at least on admission (day 0), day 7 and day 14.
Arm Title
Strategy
Arm Type
Experimental
Arm Description
Patients have to be weighed every day. Use of an algorithm based on weight changes from day 2 to day 14 in order to reduce weight gain (fluid overload) using diuretics, fluid restriction,albumin, and ultrafiltration (the latter when ongoing renal replacement)
Intervention Type
Drug
Intervention Name(s)
diuretics
Other Intervention Name(s)
hydrochlorothiazide, bumetanide, furosemide
Intervention Description
Used to reduce fluid overload as evidenced by weight gain
Intervention Type
Drug
Intervention Name(s)
albumin
Intervention Description
Used to reduce fluid overload in addition with diuretics in hypoalbuminemic patients
Intervention Type
Other
Intervention Name(s)
fluid restriction
Intervention Description
Used to reduce fluid overload
Intervention Type
Device
Intervention Name(s)
renal replacement
Other Intervention Name(s)
ultrafiltration
Intervention Description
Used to reduce fluid overload in patients with renal replacement
Primary Outcome Measure Information:
Title
All-cause mortality at 60 days after inclusion
Description
Vital status collected 60 days after admission; if the patient was dead at the time of assessment, date of death was collected
Time Frame
60 days
Secondary Outcome Measure Information:
Title
Fluid balance control at day 7
Description
Mean differences of patient body weight between Day 7 and admission (Day 0)
Time Frame
7 days
Title
Fluid balance control at day 14
Description
Mean differences of patient body weight between Day 14 and admission (Day 0)
Time Frame
14 days
Title
All-cause mortality at 28-day after inclusion
Description
Vital status collected 28 days after admission
Time Frame
28 days
Title
All-cause in-hospital mortality
Description
Death during the hospital stay where the patient was included in the study
Time Frame
Up to 24 weeks
Title
All-cause mortality at 365 days after inclusion
Description
Vital status collected one year after admission
Time Frame
365 days
Title
Survival time period at Day 60
Description
Time-related mortality, calculated from admission to the date of death
Time Frame
60 days
Title
Survival time period at Day 365
Description
Time-related mortality, calculated from admission to the date of death
Time Frame
365 days
Title
Global end-organ damage assessment
Description
Time-related changes of Sequential Organ Failure Assessment (SOFA score): SOFA is a score of organ failure with 6 subscales on organ dysfunction: respiratory, neurological, cardiovascular,hepatic,renal and coagulation. Each ranges from 0 to 4 and the total SOFA score is the sum of each subscale ; increasing severity from 0 (normal) to 24(moribund). Values of SOFA score are tightly correlated with mortality.
Time Frame
28 days
Title
Dependence on vasopressor drugs
Description
Cumulated number of vasopressor-free days alive from day 0 to day 28
Time Frame
28 days
Title
Dependence on mechanical ventilation
Description
Cumulated number of ventilator-free days alive from day 0 to day 28
Time Frame
28 days
Title
Dependence on renal replacement therapy
Description
Cumulated number of renal replacement-free days alive from day 0 to day 60
Time Frame
60 days
Title
Cumulated number of pre-defined adverse events
Description
Pre-defined adverse events include Systolic arterial pressure< 90 mm Hg, kalemia < 2,8 ,mmol/L, natremia >155 mmol/L, "injury" level of renal dysfunction (RIFLE scale), acute ischemic events (myocardial infarction, mesenteric ischemia)
Time Frame
14 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients under mechanical ventilation, admitted for > 48h and <72h and no discharge planned for the next 24h Exclusion Criteria: Age < 18 years Failure to weigh the patient Multiple trauma Transfer from another ICU with a previous stay > 24h High probability of withdrawing treatment for ethical purposes within 7 days Pregnancy Patient refusal
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
El Mehdi Siaghy
Organizational Affiliation
Central Hospital, Nancy, France
Official's Role
Study Director
Facility Information:
Facility Name
Hopital Nord Franche-Comté
City
Belfort
ZIP/Postal Code
90000
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Dijon
ZIP/Postal Code
21000
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Lyon
ZIP/Postal Code
69000
Country
France
Facility Name
Centre Hospitalier Régional
City
Metz
ZIP/Postal Code
57000
Country
France
Facility Name
Centre Hospitalier Régional et Universitaire
City
Nancy
ZIP/Postal Code
54000
Country
France
Facility Name
Groupe Hospitalier Saint Joseph
City
Paris
ZIP/Postal Code
75000
Country
France
Facility Name
Centre Hospitalier intercommunal
City
Poissy
ZIP/Postal Code
78303
Country
France
Facility Name
Centre Hospitalier Régional et Universitaire
City
Strasbourg
ZIP/Postal Code
67000
Country
France
Facility Name
CentreHospitalier Régional et universitaire
City
Strasbourg
ZIP/Postal Code
67000
Country
France
Facility Name
Centre Hospitalier Régional
City
Thionville
ZIP/Postal Code
57000
Country
France
Facility Name
Centre Hospitalier
City
Verdun
ZIP/Postal Code
55100
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31260794
Citation
Agrinier N, Monnier A, Argaud L, Bemer M, Virion JM, Alleyrat C, Charpentier C, Ziegler L, Louis G, Bruel C, Jamme M, Quenot JP, Badie J, Schneider F, Bollaert PE. Effect of fluid balance control in critically ill patients: Design of the stepped wedge trial POINCARE-2. Contemp Clin Trials. 2019 Aug;83:109-116. doi: 10.1016/j.cct.2019.06.020. Epub 2019 Jun 29.
Results Reference
background

Learn more about this trial

Effects of Fluid Balance Control in Critically Ill Patients

We'll reach out to this number within 24 hrs